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The complete amino acid sequence of the Escherichia cofi 3-dehydroquinate synthase has been determined 
by a combined nucleotide and direct amino acid sequencing strategy. E. coli 3-dehydroquinate synthase is 
362 amino acids long and has a calculated M, of 38880. Analysis of the aroB nucleotide sequence and its 
5’- and 3’-flanking regions has identified the aroB promoter elements and a possible 3’-terminator site. 
3-Dehydroquinate synthase aroB gene (Escherichia coli) Shikimate pathway 
1. INTRODUCTION 
The cyclisation of 3-deoxy-D-arabino-heptu- 
losonate-7-phosphate (DAHP) to 3-dehydro- 
quinate (DHQ) is catalysed by the enzyme 
3-dehydroquinate synthase (EC 4.6.1.3) [ 11. 
Despite the low levels at which it naturally occurs, 
the enzyme catalysing the formation of this impor- 
tant aromatic intermediate has been investigated 
[2-51, and purification to homogeneity. of 
monofunctional activities from Escherichia coli, 
Bacillus subtilis and mung bean has been reported 
[6-91. In the fungus Neurospora crassa, the DHQ 
synthase activity is the first of 5 sequential steps in 
the shikimate pathway catalysed by the pentafunc- 
tional arom enzyme complex [lo]. Of particular in- 
terest therefore is the evolutionary relationship of 
prokaryotic monofunctional DHQ synthases to 
their eukaryotic multifunctional counterparts. 
The recent successful cloning of the E. cofi aroB 
gene encoding DHQ synthase has led to the con- 
struction of overproducing strains [9,1 l] and has 
now allowed us to establish the complete amino 
acid sequence of the enzyme by a combination of 
direct amino acid sequencing and nucleotide 
sequencing. 
2. MATERIALS AND METHODS 
2.1. Reagents 
The reagents for Ml3 cloning and sequencing 
were purchased as kits from Amersham (England). 
Restriction endonucleases were purchased from 
Bethesda Research Laboratories (Paisley, 
Scotland). [a-%]dATPcrS was also purchased 
from Amersham. Avian myeloma virus reverse 
transcriptase was from Northumbria Biochemicals 
(Cramlington, England). Media reagents were 
from Difco (Detroit), 
2.2. Purification of DHQ synthase 
DHQ synthase was purified from E. coli strain 
AB28261pGM107 essentially as described by Frost 
et al. [9]. 
2.3. Automatic amino acid sequencing 
10 nmol E. coli DHQ synthase, reduced and car- 
boxymethylated as described in [ 121, was se- 
quenced as in [ 131 using a Beckman model 890 
liquid-phase sequencer. The phenylthiohydantoin 
derivatives of liberated N-terminal amino acids 
were separated and identified by chromatography 
on a Waters Resolve Cl8 reverse-phase column 
with a pH 5.0 acetate-acetonitrile buffer gradient 
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system as in [14]. PTH-methionine and PTH- 
valine derivatives co-eluted under these conditions 
and were uniquely identified on a Waters Micro 
Bondapak column using the same buffer system. 
2.4. Amino acid composition analysis 
Performic acid-oxidised E. coli DHQ synthase 
was hydrolysed in 6 N HCl as in [15] and analysed 
on an LKB model 440D amino acid analyser as in 
WI. 
2.5. DNA manipulations 
Plasmid DNA manipulations used to generate, 
select and characterise chimeric plasmids followed 
the procedures of Maniatis et al. [la]. 
pGM107 were separated by gel electrophoresis on 
low-melting-temperature agarose. The aroB- 
containing DNA fragments were excised and sub- 
jected to a secondary digest with one of the restric- 
tion enzymes HpaII, TaqI or Sau3A. The resultant 
unfractionated mixes were purified by phenol/ 
chloroform extraction and ethanol precipitation 
[16]. In addition, an intact 1.65 kbp EcoRI frag- 
ment and a 280 bp HincII fragment of insert DNA 
were purified. Extensive use was made of the Mess- 
ing series of Ml3 vectors [20] to clone these 
genomic DNA fragments. Single-stranded tem- 
plate Ml3 DNA was prepared as in [22] and stored 
at -20°C prior to sequencing. 
2.8. DNA sequencing 
2.6. Construction of pGM107 
Cloning of the E. coli aroB gene has been 
described [9,1 I]. 
Construction of the aroB-carrying plasmid 
pJB14 [9] had created two additional EcoRI 
restriction sites flanking the EcoRI site already 
present in genomic DNA used by Duncan and Cog- 
gins [ 1 l] to clone the aroB gene (see fig. 1). EcoRI 
restriction digestion of pJB14 was carried out and 
the fragments separated by electrophoresis on a 
low-melting-temperature agarose gel. A 1.65 kbp 
DNA fragment was excised and the DNA purified 
[16]. This DNA was ligated into the expression 
plasmid pKK223/3 (Pharmacia), which had been 
cut with EcoRI and treated with calf-intestinal 
phosphatase, and the ligation mix was used to 
transform E. coli aroB strain AB2826 [18]. Cells 
were plated on L agar containing ampicillin 
(50 pg/ml). Following overnight growth, colonies 
were replica-plated onto minimal medium. Ten 
colonies growing on minimal medium were picked 
and plasmid DNA extracted and analysed by 
restriction enzyme analyses [19]. A construct car- 
rying the 1.65 kbp insert in the orientation shown 
was selected and designated pGM107 (fig.1). An 
identical procedure was used to construct plasmid 
pGMlO8 except the plasmid vector used was 
suitably treated pAT153 [21]. The genomic inserts 
in plasmids pGM107 and pGMlO8 were in the 
same orientations with respect to the plasmid 
origin of replication. 
Construction of recombinant Ml3 clones al- 
lowed the use of the dideoxy chain-termination 
method for DNA sequencing [17,23]. Template 
and primer were annealed and DNA sequencing 
reactions performed as in [22]. Electrophoresis of 
reaction mixtures containing incorporated 
[a-3SS]dATPcuS was on 6% polyacrylamide gels 
(20 x 40 x 0.04 cm) [22]. Gels were dried on What- 
man 3 MM paper using a Bio-Rad model 1125 gel 
dryer and autoradiography was overnight at room 
temperature with Fuji RX film. 
2.9. Transcript mapping 
RNA was prepared [27] from exponentially 
growing E. coli AB2826 transformed with either 
pGM107 or pGM108. A synthetic oligonucleotide 
primer, 25 nucleotides long (sequence 
5 ’ -GGTAATTGGGTAACTACGTTCCCCG-3 ’ ), 
complementary to nucleotides 24-48 in the aroB 
coding sequence was annealed to the RNA at 55°C 
for 30 min in 10 mM Tris-HCl buffer (pH 8.5), 
containing 10 mM MgClz. Primer extension syn- 
thesis of the run-off transcripts was carried out by 
adding 10&i [cu-35S]dATPcuS and dGTP, dCTP 
and dTTP to a final concentration of 0.1 mM and 
avian myeloma virus reverse transcriptase (23 
units). Incubation was at 30°C for 30 min. Run- 
off transcripts were analysed using polyacrylamide 
sequencing els. 
3. RESULTS AND DISCUSSION 
2.7. Preparation of DNA for sequencing Takeda et al. [25] have shown that the Clarke 
The DNA fragments of several EcoRI digests of and Carbon plasmid pLC29-47 [24] carries the 
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ponA gene which lies adjacent to aroB on the E. 
coli chromosome. Independent sub-cloning from 
pLC29-47 has further demonstrated that the aroB 
gene lies within a 3.6 kbp EcoRI-BgflI fragment 
(pKD106) [ll] and on a 2.5 kbp MspI fragment 
(pJBl4) [9]. Restriction mapping and hybridisa- 
tion analysis (not shown) established that these two 
aroB clones both contained a common 1.65 kbp 
region of E. coli genomic DNA. This 1.65 kbp 
fragment was further sub-cloned to yield plasmids 
pGM107 and pGM108, each of which retained 
both the ability to relieve the auxotrophic re- 
quirements of E. coli AB2826 and to overexpress 
3-dehydroquinate synthase activity. The 1.65 kbp 
sub-clone, PGM107 (fig.l), was used as starting 
material for DNA sequence analysis, and the 
transformed strain AB2826/pGM107 used as 
source for protein purification. 
The DNA sequencing strategy is summarised in 
fig.2, and involved the alignment of the sequences 
obtained from the various HpaII, HincII, Sau3A 
and 7’aqI Ml3 sub-clones until all the restriction 
sites that had been used were overlapped and the 
DNA sequence had been determined on both 
strands. The complete sequence, including the 
EcoRI recognition sites used to generate pGM107, 
totalled 1644 bp in length. The sequence was 
analysed on both strands for possible open reading 
frames and one, extending some 1100 bp from 
positions 438 to 1544 in the nucleotide sequence, 
was identified. Evidence that this was a coding 
region was obtained by using a computer program 
which examines the positional base frequencies in 
all 3 reading frames [28]. 
Two methionine (ATG) codons at positions 456 
and 557, close to the beginning of the open reading 
frame were identified as possible translational in- 
itiation sites. Direct N-terminal amino acid se- 
quencing of the purified 3-dehydroquinate syn- 
thase confirmed that this open reading frame was 
the E. coli DHQ synthase coding sequence and that 
the Met codon at position 456 was the translational 
start site. Located 11 bp upstream of this codon is 
the sequence GGTGG which exhibits homology 
with the consensus sequence for the E. coli 
ribosome binding site, GGAGG [29]. 
The complete E. coli aroB gene nucleotide se- 
quence is shown in fig.4. The predicted amino acid 
sequence corresponds to a protein of calculated M, 
38880 containing 362 amino acid residues. SDS- 
polyacrylamide gel electrophoresis [26] of the 
purified 3-dehydroquinate synthase demonstrated 
that the enzyme was homogeneous (not shown) 
and had a subunit M, of 38000-39000. Both 
values are in agreement with the published value 
for the purified enzyme [9]. The first 45 N-terminal 
amino acids were identified (fig.3) and agreed ex- 
actly with the amino acid sequence predicted from 
-pKDlOB (a) 
pJBl4 (b) 
pGMl07 k) 
u 
300bp 
Fig.1. Construction of pGM107. Restriction enzyme digest profiles of both aroB-carrying plasmids pKD106 (a) and 
pJB14 (b) were compared and aligned. Genomic DNA is represented by the boxed areas, solid lines show vector DNA. 
The hatched area indicates the region of overlap sub-cloned as pGM107 (c). The direction of transcription of the oroB 
is shown. Note the two additional EcoRI sites, flanking the genomic EcoRI site, in pJBl4 generated as cloning artefacts. 
Plasmid pGM108 contains the same genomic insert as pGM107 except cloned in pATl53. 
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Fig.2. Sequencing strategy for the aroB gene. The boxed 
area above the restriction map represents the 
3-dehydroquinate synthase coding region; the shaded 
region defines the extent of the N-terminal amino acid 
sequencing. The length and orientation of sub-clones 
used in the sequence analysis are represented byarrows 
and the relevant restriction sites are shown. 
the nucleotide data. The amino acid composition 
determined experimentally was also in good agree- 
ment with that deduced from the DNA sequence 
(table 1). Transcript mapping analysis of the aroB- 
encoding mRNA using reverse transcriptase- 
directed DNA synthesis from a synthetic 
oligonucleotide primer identified an A residue 
(position 356), 100 bp upstream of the transla- 
tional start site, as the 5’-end of the aroB mRNA 
(fig.4). Secondary structure formation at the 
5 ‘-end of the mRNA results in a number of 
premature terminations of run-off transcripts (see, 
for example, position (ii) in fig.5). However, the 
longest run-off band (indicated at position (i) in 
fig.5) maps accurately at position 356. Analysis of 
RNA prepared from E. coli AB2826 transformed 
1 10 
Met - Glu - Arg - Ile - Val - Val - Thr - Leu - Gly - Glu - 
11 20 
Arg - Ser - Tyr - Pro - Ile - Thr - Ile - Ala - Ser - Gly - 
21 30 
Leu - Phe - Am - Glu - Pro - Ala - Ser - Phe - Leu - Pro - 
31 40 
Leu - Lys - Ser - Gly - Glu - Gin - Val - Met - Leu - Val - 
41 45 
(-) - Asn - Glu - C-1 - Leu 
Fig.3. The N-terminal amino acid sequence of 
3-dehydroquinate synthase. The sequence was 
determined on a liquid-phase sequencer as described in 
section 2.3. The initial amount of protein sequenced was 
5.5 nmol and the repetitive yield from residue 1 to 45, by 
least-squares regression analysis, was 95%. Residues 41 
and 44 could not be unambiguously identified. 
with either pGM107 or pGM108 gave the same 
result. The location of both the full-length reverse 
run-off transcript band and the major premature 
termination species are identical for both pGM107- 
and pGM108-derived aroB mRNAs. This identifies 
the natural aroB promoter and precludes the 
possibility that expression of aroB in construct 
pGM107 may be from an artificially long 
transcript originating at or near the powerful vec- 
tor iac promoter. 
Immediately upstream of the transcriptional 
start site are sequences with considerable 
homology to the consensus E. coli - 35 and - 10 
promoter sequences elements [30]. The aroB pro- 
moter - 10 region (GATGAT) is separated by 
17 bp, the optimal separation, from the -35 
region (TTGCCG). Analysis of the aroB promoter 
elements reveals that only 3 strongly conserved 
base pairs differ from those of the ‘standard’ E. 
coli promoter [30]. Immediately 3 ‘- to the end of 
the aroB gene, and starting at position 1588 (fig.4), 
is a sequence capable of forming a stem-loop struc- 
ture characteristic of a rho-independent terminator 
(fig.6). A free energy of formation (AC) was 
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Fig.4. The complete aroB coding sequence together with 
the 3 ‘- and 5 ‘-flanking sequences. The DNA sequence 
of the complete 1644 bp EcoRI fragment cloned in 
pGM107 and pGM108 is shown and numbered. The 
numbered amino acids in the aroB coding region are 
indicated [ 1. The translational start site is preceded by 
the proposed ribosome binding site (RBS). The aroB 
transcriptional start site is indicated (+ 1) and the 
promoter sequences upstream compared with the 
consensus - 35 and - 10 sequences. The location of an 
inverted repeat 3’- to the end of the aroB gene is 
indicated by overlining. 
calculated by the rules of Tinoco et al. [3 l] and the 
negative value obtained suggests that this stem 
loop may form a stable secondary structure in 
vivo. This sequence may form part of an aro3 ter- 
minator. The codon ut~isation of the aroZ3 gene 
Table 1 
The amino acid composition ofE. coli 3-dehydroquinate 
synthase compared with that predicted from the DNA 
sequence of the E. co/i aroB gene 
Amino 
acid 
Relative amino Theoretical amino 
acid composition acid composition 
based on deduced from 
Leu = 49 residues aroB DNA sequence 
cyst 5.1 5 
Asx 26.1 26 
Meta 9.2 10 
Thrb 16.2 18 
Serb 21.1 20 
Glx 40.5 36 
Pro 16.5 16 
Gly 36.5 34 
Alab 36.8 39 
Val 30.0 32 
Be 13.7 16 
Leu 49 49 
TYr 6.1 9 
Phe 9.8 10 
His 6.7 7 
LYS 12.8 13 
Arg 20.6 20 
Trp nd 2 
8 Determined as methionine sulphone 
b Experimental vaiues extrapolated to zero time 
c Determined as cysteic acid 
nd, not determined 
has been examined, and is similar to that of other 
E. cofi genes which are weakly expressed 136,371. 
Although differing in divalent metal ion re- 
quirements [1,321 a common feature of the DHQ 
synthase activities of N. crassa and E. coli is a 
cataiytic requirement for NAD” [1,321. It is 
recognised that many nucl~tide-binding proteins 
contain a region of conserved amino acid sequence 
[33,38] involved in nucleotide binding. One such 
structural motif (or ‘fingerprint’) has been de- 
scribed in detail for several NAD+- and FAD- 
linked enzymes [33]. The key structural feature is 
a conserved ammo acid sequence contained within 
a &?-cu$? secondary structure [33]. This conserved 
sequence contains 3 glycine residues arranged Gly- 
X-Gly-X-X-Gly, an invariant hydrophobic amino 
acid 4 residues before this sequence, and an in- 
variant negatively charged ammo acid 18-20 
15 
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(i) 
Fig.S. Transcript mapping of the aroB gene. Tracks A, 
C, G, T represent he relevant sequencing ladders of a 
recombinant Ml3 clone carrying the E. coli aroB gene. 
Track 1 shows the reverse run-off products of 
o~igonucl~tide primer extension of pGM107-derived 
mRNA. The same ohgonucleotide primer was used for 
both the sequencing and the reverse run-off synthesis 
reactions. Indicated as (i) is the full-length reverse run- 
off band; the significance of band (ii) is discussed in the 
text. The sequence at the transcriptional start site is 
shown and the exact start encircled. 
I6 
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TG 
G G 
C 1 
A A 
A A 
C.G 
AG = -11,4 kcal 
1583 G’C 
i CA TTTTAGT 
GCTT 
Fig.6. Possible aroB terminaror sequence. Shown is the 
sequence 3 I- to the end of the E. mfi ar& gene indicated 
by overlining in fig.4) as a possibie stem loop structure. 
residues after the last conserved glycine. Also con- 
tained within this 30-32 residue ‘domain’ are 
several conserved hydrophobia residues forming 
the hydrophobic core of the unit [331. Alignment 
of this adenine nucleotide-binding site has been 
demonstrated for several flavoproteins and 
dehydrogenases that bind FAD or NAD+, in- 
cluding E. coff NADH dehydrogenase, human 
glutathione reductase, dogfish lactate dehydro- 
genase, E. co& lipoamide dehydrogenase and E, 
cali chorismate mutaseiprephenate dehydrogenase 
[34]. Although the E. coli DHQ synthase uses 
NAD+ as a prosthetic group and not as a coenzyme 
131, a comparison of the enzyme sequence with that 
of the proposed fi~gerp~nt does reveal some in- 
teresting similarities. Residues 96-126 of the E. 
coii DHQ synthase sequence have a predicted 
secondary structure of ,&& [35] which with the 
exception of the invariant negatively charged 
residues (where the E. coci DHQ synthase sequence 
has a Gin residue) contains ah of the conserved 
features of this fingerprint model. The availability 
of overproducing strains that readily yield 100 mg 
quantities of E. cofi J-dehydroquinate synthase [9] 
should soon allow X-ray crystallography to be 
used to confirm the significance of this homoIogy. 
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